Sign up to save your podcasts
Or
Share BCMA Who and When: Immunotherapies in Patients with RRMM
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
BCMA Who and When: Immunotherapies in Patients with RRMM
CME credits: 1.00
Valid until: 10-01-2024
Claim your CME credit at https://reachmd.com/programs/cme/bcma-who-and-when-immunotherapies-in-patients-with-rrmm/14729/
Given the complexity of care for patients with multiple myeloma (MM) and the mounting clinical trial data, it is crucial to stay abreast of investigational agents and new data from current agents. Join Drs. Saad Usmani, Sikander Ailawadhi, and Amrita Krishnan as they explore new and emerging ways to close medical gaps in treatment and provide clinically applicable information to optimize outcomes for patients with MM. This enduring program will cover practical case illustrations, recent data released at the ASH annual meeting, and more!
=
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 1.00
Valid until: 10-01-2024
Claim your CME credit at https://reachmd.com/programs/cme/bcma-who-and-when-immunotherapies-in-patients-with-rrmm/14729/
Given the complexity of care for patients with multiple myeloma (MM) and the mounting clinical trial data, it is crucial to stay abreast of investigational agents and new data from current agents. Join Drs. Saad Usmani, Sikander Ailawadhi, and Amrita Krishnan as they explore new and emerging ways to close medical gaps in treatment and provide clinically applicable information to optimize outcomes for patients with MM. This enduring program will cover practical case illustrations, recent data released at the ASH annual meeting, and more!
=